| Health / Medical Topics |
CDK Inhibitor SNS-032
A small aminothiazole molecule and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. SNS-032 binds to and prevents the phosphorylation of cyclin-dependent kinases, especially CDK2, 7, and 9 that regulate cell cycle progression. Inhibition of CDKs leads to cell cycle arrest and induces apoptosis. As a result, this agent causes cytotoxicity and prevents further tumor cell growth. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks…
CDK Inhibitor Proteins, encoded by the CDK Inhibitor genes, are a group of low molecular weight proteins that associate with cyclin-CDK complexes…
A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin D1, Cdk1/cyclin B…
A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to…
The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables.
This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of…
